Assessing the role of sleep in reducing risk and improving outcomes for breast cancer
Chief Investigator
|
Institution
|
Dates
|
Funding Stream
|
Amount
|
Dr Rebecca Richmond |
University of Bristol |
06/01/2020 to 09/02/2025
|
Above and Beyond Breast Cancer Legacies 2019
|
£101,953 |
Summary
There is an extensive literature surrounding the impact
disturbance to the body clock has on breast cancer risk, although
much of the evidence comes from studies on animal rather than
humans. While previous human studies have focused on the potential
carcinogenic effect of night shift work, we have recently
investigated the impact of sleep on breast cancer risk using data
from women enrolled in large population-based studies. We found
that women who woke earlier and who slept longer seemed to be less
likely to get breast cancer. However, we do not know why this is
and further work to understanding potential mechanisms is required.
In addition, looking at the influence of sleep preference (e.g.
morning/evening preference) vs. actual sleep patterns requires
further exploration. Understanding the timing of risk is also
necessary to assess whether sleep patterns are important at certain
times in the life-course so that interventions can be developed to
support that. Related to this is the need to evaluate whether sleep
has an influence on outcomes such as survival, recurrence and
treatment success among women diagnosed with breast cancer.
Finally, an assessment of potential interventions to improve sleep
among women diagnosed with, or at high risk of, breast cancer is
needed, including evaluating the perceived importance of sleep and
acceptability of interventions within a clinical setting. There is
an extensive literature surrounding the impact disturbance to the
body clock has on breast cancer risk, although much of the evidence
comes from studies on animal rather than humans. While previous
human studies have focused on the potential carcinogenic effect of
night shift work, we have recently investigated the impact of sleep
on breast cancer risk using data from women enrolled in large
population-based studies. We found that women who woke earlier and
who slept longer seemed to be less likely to get breast cancer.
However, we do not know why this is and further work to
understanding potential mechanisms is required. In addition,
looking at the influence of sleep preference (e.g. morning/evening
preference) vs. actual sleep patterns requires further exploration.
Understanding the timing of risk is also necessary to assess
whether sleep patterns are important at certain times in the
life-course so that interventions can be developed to support that.
Related to this is the need to evaluate whether sleep has an
influence on outcomes such as survival, recurrence and treatment
success among women diagnosed with breast cancer. Finally, an
assessment of potential interventions to improve sleep among women
diagnosed with, or at high risk of, breast cancer is needed,
including evaluating the perceived importance of sleep and
acceptability of interventions within a clinical setting.